Repositioning and Characterization of 1-(Pyridin-4-yl)pyrrolidin-2-one Derivatives as Plasmodium Cytoplasmic Prolyl-tRNA Synthetase Inhibitors.

MLA

Okaniwa, Masanori, et al. “Repositioning and Characterization of 1-(Pyridin-4-Yl)Pyrrolidin-2-One Derivatives as Plasmodium Cytoplasmic Prolyl-TRNA Synthetase Inhibitors.” ACS Infectious Diseases, vol. 7, no. 6, June 2021, pp. 1680–89. EBSCOhost, https://doi.org/10.1021/acsinfecdis.1c00020.

APA

Okaniwa, M., Shibata, A., Ochida, A., Akao, Y., White, K. L., Shackleford, D. M., Duffy, S., Lucantoni, L., Dey, S., Striepen, J., Yeo, T., Mok, S., Aguiar, A. C. C., Sturm, A., Crespo, B., Sanz, L. M., Churchyard, A., Baum, J., Pereira, D. B., … Laleu, B. (2021). Repositioning and Characterization of 1-(Pyridin-4-yl)pyrrolidin-2-one Derivatives as Plasmodium Cytoplasmic Prolyl-tRNA Synthetase Inhibitors. ACS Infectious Diseases, 7(6), 1680–1689. https://doi.org/10.1021/acsinfecdis.1c00020

Chicago

Okaniwa, Masanori, Akira Shibata, Atsuko Ochida, Yuichiro Akao, Karen L White, David M Shackleford, Sandra Duffy, et al. 2021. “Repositioning and Characterization of 1-(Pyridin-4-Yl)Pyrrolidin-2-One Derivatives as Plasmodium Cytoplasmic Prolyl-TRNA Synthetase Inhibitors.” ACS Infectious Diseases 7 (6): 1680–89. doi:10.1021/acsinfecdis.1c00020.